Latest Articles
Endometriosis-Associated Infertility: Multi-Omics Insights into Pathogenesis and Precision Therapeutics - Frontiers
Endometriosis-Associated Infertility: Multi-Omics Insights into Pathogenesis and Precision Therapeutics Frontiers
Published: Aug. 15, 2025, 1:08 p.m.
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights The Manila Times
Published: Aug. 13, 2025, 8:31 p.m.
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewswire
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights GlobeNewswire
Published: Aug. 13, 2025, 8:17 p.m.
Karyopharm Therapeutics Inc. SEC 10-Q Report - TradingView
Karyopharm Therapeutics Inc. SEC 10-Q Report TradingView
Published: Aug. 11, 2025, 11:43 a.m.
Precision Therapeutic and Preventive Molecular Strategies for Endometriosis-Associated Infertility.
Endometriosis, a chronic estrogen-dependent disorder defined by ectopic endometrial-like tissue growth, causes pelvic pain and infertility in reproductive-age women. Despite its prevalence, the underlying mechanisms driving lesion persistence and reproductive …
Published: Aug. 9, 2025, midnight
Lisata Therapeutics Q2 2025: Key Contradictions in ASCEND Trial Insights and Financial Projections - AInvest
Lisata Therapeutics Q2 2025: Key Contradictions in ASCEND Trial Insights and Financial Projections AInvest
Published: Aug. 8, 2025, 7:14 a.m.
Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer - TipRanks
Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer TipRanks
Published: Aug. 7, 2025, 4:18 p.m.
Onconic Therapeutics announced on the 28th that "Nesuparib," a candidate for a double-targeted antic.. - 매일경제
Onconic Therapeutics announced on the 28th that "Nesuparib," a candidate for a double-targeted antic.. 매일경제
Published: July 28, 2025, 6:56 a.m.
Universal Quantum Joins Institute To Advance Endometrius Therapeutics - Quantum Zeitgeist
Universal Quantum Joins Institute To Advance Endometrius Therapeutics Quantum Zeitgeist
Published: July 24, 2025, 11:09 a.m.
Endometriosis Therapeutics: A Market in Need, but Can Organon Still Lead? - AInvest
Endometriosis Therapeutics: A Market in Need, but Can Organon Still Lead? AInvest
Published: July 2, 2025, 1:04 p.m.
Link copied to clipboard!